MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CINTI, D. L.
Right arrow Articles by SCHENKMAN, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CINTI, D. L.
Right arrow Articles by SCHENKMAN, J. B.

Molecular Pharmacology, Vol 8, 327-338, Copyright © 1972 by the American Society for Pharmacology and Experimental Therapeutics

Hepatic Organelle Interaction

I. Spectral Investigation During Drug Biotransformation

D. L. CINTI 1 and J. B. SCHENKMAN 1

1 Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510

A technique which permits the measurement of levels of mitochondrial and endoplasmic reticulum pigments in the hepatocyte, the examination of changes in the oxidation-reduction states of these pigments, and the study of interactons between the mitochondrial and endoplasmic reticulum electron transport chains is described. The content of cytochrome P-450 was about 30 nmoles/g of liver, wet weight. Based on the microsomal concentration of cytochrome P-450, the microsomal protein content ranged from 50 to 70 mg/g of liver. The total mitochondrial pigment concentration was 83 nmoles/g of liver, wet weight, and 1.16 nmoles/mg of mitochondrial protein. Based on these figures there were about 75 mg of mitochondrial protein per gram of liver. The rate of reduction of cytochrome P-450 in liver slices was also measured; the endogenous rate of reduction was 1.5-3.0 nmoles/g of liver per minute, and it increased to 4.5 nmoles/g/min in the presence of NADPH. The addition of 8 mM aminopyrine doubled the rate of reduction of cytochrome P-450 to 5.0-6.0 nmoles. When a Krebs cycle intermediate such as succinate was added in the presence of aminopyrine, a further doubling of the rate of reduction of cytochrome P-450 occurred (9.0-10.0 nmoles/g of liver per minute). The presence of succinate in the medium containing both aminopyrine and NADPH increased the P-450 reductase activity synergistically to 23 nmoles/g of liver per minute. These data indicate that the mitochondria may be a site of cellular control of drug biotransformation in the endoplasmic reticulum.

Note:
ACKNOWLEDGMENT The authors express their thanks to Dr. Joan Higgins of the Department of Anatomy, Yale University, for the interpretation of the electron micrographs.

Submitted on December 8, 1971




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
D. J. Carlile, K. Zomorodi, and J. B. Houston
Scaling Factors to Relate Drug Metabolic Clearance in Hepatic Microsomes, Isolated Hepatocytes, and the Intact Liver. Studies with Induced Livers Involving Diazepam
Drug Metab. Dispos., August 1, 1997; 25(8): 903 - 911.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1972 by the American Society for Pharmacology and Experimental Therapeutics